Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Net operating loss carryforwards	$ 14,145,000	$ 10,771,000
Accrued expenses	1,809,000	2,125,000
Research and development credit carryforwards	938,000	938,000
Stock-based compensation	7,919,000	7,848,000
Deferred tax assets before valuation allowance	24,811,000	21,682,000
Less: Valuation allowance	(24,811,000)	(21,682,000)
Net deferred income tax assets
Deferred tax liabilities
Net deferred tax assets (liabilities)